|
Wysocka, Maria; Zaki, Mohamed H; French, Lars E et al. (2002) Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines. Blood 100:3287-94
|
|
Wysocka, M; Robertson, S; Riemann, H et al. (2001) IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J Immunol 166:7504-13
|
|
Trinchieri, G; Scott, P (1999) Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol 238:57-78
|
|
Marshall, J D; Chehimi, J; Gri, G et al. (1999) The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 94:1003-11
|
|
Kubin, M Z; Parshley, D L; Din, W et al. (1999) Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48. Eur J Immunol 29:3466-77
|
|
Fox, F E; Kubin, M; Cassin, M et al. (1999) Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cells. J Interferon Cytokine Res 19:407-15
|
|
Monteiro, J M; Harvey, C; Trinchieri, G (1998) Role of interleukin-12 in primary influenza virus infection. J Virol 72:4825-31
|
|
Schwarz, A; Grabbe, S; Grosse-Heitmeyer, K et al. (1998) Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. J Immunol 160:4262-70
|
|
Peritt, D; Robertson, S; Gri, G et al. (1998) Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 161:5821-4
|
|
Constantinescu, C S; Hondowicz, B D; Elloso, M M et al. (1998) The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis. Eur J Immunol 28:2227-33
|
Showing the most recent 10 out of 105 publications
